ciglitazone has been researched along with dinoprostone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 11 (68.75) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brimacombe, KR; Duveau, DY; Hu, X; Jadhav, A; Kouznetsova, J; Maloney, DJ; Simeonov, A; Thomas, CJ; Wang, Y; Yasgar, A | 1 |
| Gebicke-Haerter, PJ; Kakimura, J; Kitamura, Y; Matsuoka, Y; Nomura, Y; Taniguchi, T | 1 |
| Baik, EJ; Kim, EJ; Kwon, KJ; Lee, SH; Moon, CH; Park, JY | 1 |
| Cho, H; Tai, HH | 1 |
| Corbett, L; Knox, AJ; Nie, M; Pang, L | 1 |
| Ajmone-Cat, MA; Bernardo, A; Levi, G; Minghetti, L | 1 |
| Benoit, V; Bours, V; Franchimont, N; Gillet, P; Kaiser, MJ; Malaise, MG; Merville, MP; Relic, B; Ribbens, C | 1 |
| D'Aprile, A; Henry, PJ; Hong, T; Mann, TS; Self, G | 1 |
| Konger, RL; Seltmann, H; Zhang, Q; Zouboulis, CC | 1 |
| Han, MJ; Han, MK; Kim, EK; Koo, BS; Kwon, KB; Park, BH; Park, JW; Ryu, DG; Song, EK; Song, MY | 1 |
| Futagami, M; Mizunuma, H; Shigeto, T; Xin, B; Yokoyama, Y | 1 |
| Dubinett, SM; Hazra, S | 1 |
| Jang, SK; Kim, JH; Kim, WJ | 1 |
| Kawabata, A; Maeda, Y; Nishikawa, H; Sekiguchi, F; Shigi, H; Takaoka, K | 1 |
| Mizunuma, H; Shigeto, T; Xin, B; Yokoyama, Y | 1 |
| Arosh, JA; Banu, SK; Kavoussi, SK; Lebovic, DI; Lee, J | 1 |
16 other study(ies) available for ciglitazone and dinoprostone
| Article | Year |
|---|---|
Structure-activity relationship studies and biological characterization of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors.
Topics: Cell Line, Tumor; Enzyme Inhibitors; Humans; Hydroxyprostaglandin Dehydrogenases; NAD; Structure-Activity Relationship | 2014 |
Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells.
Topics: Alitretinoin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cells, Cultured; Dinoprostone; Enzyme Induction; Gene Expression Regulation, Enzymologic; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Interferon-gamma; Lipopolysaccharides; Neuroglia; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Prostaglandin D2; Pyrimidines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin | 1999 |
Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2.
Topics: Animals; Cell Culture Techniques; Cell Death; Chromans; Clofibrate; Cyclooxygenase 2; Dinoprostone; Electrophoretic Mobility Shift Assay; Escherichia coli; Immunohistochemistry; In Situ Nick-End Labeling; Isoenzymes; Lipopolysaccharides; Mice; Mice, Inbred ICR; Neurons; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxisome Proliferators; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2002 |
Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Hydroxyprostaglandin Dehydrogenases; Inhibitory Concentration 50; Isoenzymes; Kinetics; Membrane Proteins; NAD; Placenta; Prostaglandin-Endoperoxide Synthases; Thiazoles; Thiazolidinediones | 2002 |
Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors.
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cell Survival; Cyclooxygenase 2; Dexamethasone; Dinoprostone; Flurbiprofen; Humans; Indomethacin; Isoenzymes; Lung; Membrane Proteins; Muscle, Smooth; NF-kappa B; Nitrobenzenes; Promoter Regions, Genetic; Prostaglandin Antagonists; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Protein Transport; Receptors, Cytoplasmic and Nuclear; Response Elements; Sulfonamides; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation | 2003 |
15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms.
Topics: Animals; Apoptosis; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Isoenzymes; Lipopolysaccharides; Microglia; Nitric Oxide; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Rats; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thiazolidinediones; Transcription Factors | 2003 |
15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts.
Topics: Annexin A5; Anti-Infective Agents; Apoptosis; Blotting, Western; Cartilage; Cartilage, Articular; Cell Survival; Cells, Cultured; Chondrocytes; Coloring Agents; Cysteine Endopeptidases; Dinoprost; Dinoprostone; Down-Regulation; Fibroblasts; Humans; I-kappa B Proteins; Immunologic Factors; Leupeptins; Mitogen-Activated Protein Kinases; Multienzyme Complexes; Mutation; NF-kappa B; NF-KappaB Inhibitor alpha; Nitriles; Phosphorylation; Prostaglandin D2; Proteasome Endopeptidase Complex; Receptors, Cytoplasmic and Nuclear; Sulfones; Synovial Membrane; Thiazolidinediones; Transcription Factors | 2004 |
Inhibitors of prostaglandin transport and metabolism augment protease-activated receptor-2-mediated increases in prostaglandin E2 levels and smooth muscle relaxation in mouse isolated trachea.
Topics: Animals; Antiporters; Bromcresol Green; Dinoprostone; DNA-Binding Proteins; Female; Hydroxyprostaglandin Dehydrogenases; Immunohistochemistry; Mice; Mice, Inbred BALB C; Muscle Relaxation; Oligopeptides; Organic Anion Transporters; PPAR gamma; Receptor, PAR-2; Rosiglitazone; Thiazolidinediones; Trachea | 2005 |
Involvement of PPARgamma in oxidative stress-mediated prostaglandin E(2) production in SZ95 human sebaceous gland cells.
Topics: Anilides; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Epidermis; Humans; Oxidants; Oxidative Stress; PPAR gamma; RNA, Messenger; Sebaceous Glands; tert-Butylhydroperoxide; Thiazolidinediones; Ultraviolet Rays | 2006 |
Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway.
Topics: Adenoviridae; Animals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromans; Cytokines; Dinoprostone; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; I-kappa B Proteins; Insulin; Insulin-Secreting Cells; Interleukin-1beta; Male; Mutation; NF-kappa B; NF-KappaB Inhibitor alpha; Nitrites; PPAR gamma; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazolidinediones; Troglitazone | 2007 |
Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
Topics: Animals; Apoptosis; Ascites; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Female; Humans; Immunohistochemistry; Intramolecular Oxidoreductases; Meloxicam; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Peritoneal Neoplasms; PPAR gamma; Prostaglandin-E Synthases; Survival Analysis; Thiazines; Thiazoles; Thiazolidinediones; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2007 |
Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Humans; Hydroxyprostaglandin Dehydrogenases; Intramolecular Oxidoreductases; Lung Neoplasms; PPAR gamma; Promoter Regions, Genetic; Prostaglandin-E Synthases; Response Elements; RNA, Messenger; Signal Transduction; Thiazolidinediones | 2007 |
Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A.
Topics: Anti-Inflammatory Agents; Arachidonic Acid; Arsenites; Chromans; Cyclopentanes; Cytoplasmic Granules; Dinoprostone; Emetine; Enzyme Inhibitors; Eukaryotic Initiation Factor-2; Eukaryotic Initiation Factor-4A; Gene Expression Regulation; HeLa Cells; Humans; Hypoglycemic Agents; Inflammation; Poly(A)-Binding Proteins; PPAR gamma; Prostaglandin D2; Prostaglandins A; Protein Biosynthesis; Protein Synthesis Inhibitors; Rosiglitazone; Signal Transduction; Sodium Compounds; T-Cell Intracellular Antigen-1; Thiazolidinediones; TNF Receptor-Associated Factor 2; Troglitazone; Tumor Necrosis Factor-alpha | 2007 |
Opposite effects of two thiazolidinediones, ciglitazone and troglitazone, on proteinase-activated receptor-1-triggered prostaglandin E(2) release.
Topics: Animals; Base Sequence; Cell Line; Chromans; Dinoprostone; DNA Primers; Gastric Mucosa; Phosphorylation; Polymerase Chain Reaction; Rats; Receptor, PAR-1; Signal Transduction; Thiazolidinediones; Troglitazone | 2010 |
Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Ascites; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Drug Synergism; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; In Situ Nick-End Labeling; Intramolecular Oxidoreductases; Mice; Mice, Nude; Microcirculation; Neovascularization, Pathologic; Ovarian Neoplasms; Peritoneal Neoplasms; PPAR gamma; Prostaglandin-E Synthases; Receptors, Prostaglandin E, EP3 Subtype; Thiazolidinediones; Transplantation, Heterologous; Treatment Outcome; Vascular Endothelial Growth Factor A | 2011 |
PPARĪ³ activation inhibits growth and survival of human endometriotic cells by suppressing estrogen biosynthesis and PGE2 signaling.
Topics: Aromatase; Cell Line; Dinoprostone; Endometrium; Epithelial Cells; Female; Gene Expression Regulation; Humans; Hypoglycemic Agents; PPAR gamma; Receptors, Prostaglandin; Thiazolidinediones | 2013 |